Original paper
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Volume: 117, Issue: 17, Pages: 9490 - 9496
Published: Apr 6, 2020
Abstract
Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as an addition to maximal supportive care and antiviral agents. The primary...
Figures & Tables
Fig. 1. Chest CTs of two patients. (A) Chest CT of patient 9 obtained on Februar...
Paper Details
Title
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Published Date
Apr 6, 2020
Volume
117
Issue
17
Pages
9490 - 9496
TrendsPro
You’ll need to upgrade your plan to Pro
Looking to understand a paper’s academic impact over time?
- Scinapse’s Citation Trends graph enables the impact assessment of papers in adjacent fields.
- Assess paper quality within the same journal or volume, irrespective of the year or field, and track the changes in the attention a paper received over time.
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.